Continuous renal replacement therapies in sepsis: Where are the data?

Nephrology Dialysis Transplantation

Volumn 13, Issue 6, 1998, Pages 1362-1364

  De Vriese, An S ^a   Vanholder, Raymond C ^a   De Sutter, Johan H ^a   Colardyn, Francis A ^a   Lameire, Norbert H ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL EFFECTIVENESS; CONTINUOUS HEMOFILTRATION; CONTINUOUS RENAL REPLACEMENT THERAPY; CRITICALLY ILL PATIENT; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; EXPERIMENTAL STUDY; HEART FUNCTION; HOMEOSTASIS; HUMAN; IN VITRO STUDY; INFLAMMATORY DISEASE; KIDNEY BLOOD FLOW; KIDNEY FAILURE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY FUNCTION; REVIEW; SEPSIS; SURVIVAL; ARTICLE; DIALYSIS; HEMODYNAMICS; MEDIATOR;

EID: 0031800214     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a027894     Document Type: Review

References (34)

1. van Bommel EF. Are continuous therapies superior to intermittent haemodialysis for acute renal failure on the intensive care unit? Nephrol Dial Transplant 1995; 10: 311-314
2. Schetz M, Ferdinande P, Van den Berghe G, Verwaest C, Lauwers P. Removal of pro-inflammatory cytokines with renal replacement therapy: sense or nonsense? Intensive Care Med 1995; 21: 169-176
3. Barrera P, Janssen EM, Demacker PN, Wetzels JF, van der Meer JW. Removal of Interleukin-lβ and tumor necrosis factor from human plasma by in vitro dialysis with polyacrylonitrile membranes. Lymphokine Cytokine Res 1992; 11: 99-104
4. Goldfarb S, Golper TA. Proinflammatory cytokines and hemo-filtration membranes. J Am Soc Nephrol 1994; 5: 228-232
5. Cheung AK, Parker CJ, Wilcox LA, Janatova J. Activation of complement by hemodialysis membranes: polyacrylonitrile binds more C3a than cuprophan. Kidney Int 1990; 37: 1055-1059
6. Pascual M, Schififerli JA. Adsorption of complement factor D by polyacrylonitrile dialysis membranes. Kidney Int 1993; 43: 903-911
7. Amato M, Cozzolino F, Bergesio F, Salvadori M, Torcia MG, Carossino A, Sodi A. In vitro Interleukin-1 production by different dialysis membranes. Nephrol Dial Transplant 1988; 3: 432-434
8. Kierdorf H, Melzer H, WeiBen D, Heintz B, Sieberth HG. Elimination of tumor necrosis factor by continuous venovenous hemofiltration. Ren Fail 1992; 14: 98 (Abstract)
9. Heering P, Morgera S, Schmitz FJ, Schmitz G, Willers R, Schultheiss HP, Strauer BE, Grabensee B. Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration. Intensive Care Med 1997; 23: 288-296
10. Hoffman JN, Hartl WH, Deppisch R, Faist E, Jochum M, Inthorn D. Effect of hemofiltration on hemodynamics and systemic concentrations of anaphylatoxins and cytokines in human sepsis. Intensive Care Med 1996; 22: 1360-1367
11. Cottrell AC, Mehta RL. Cytokine kinetics in septic ARF patients on continuous veno-venous hemodialysis. J Am Soc Nephrol 1992; 3: 361 (Abstract)
12. Bellomo R, Tipping P, Boyce N. Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med 1993; 21: 522-526
13. Elliott D, Wiles III CE, Reynolds HN. Removal of cytokines in septic patients using continuous veno-venous hemodiafiltration. Crit Care Med 1994; 22: 718-719 (Letter)
14. Sander A, Armbuster W, Sander B, Daul AE, Lange R, Peters J. Hemofiltration increases 11-6 clearance in early systemic inflammatory response syndrome but does not alter 11-6 and TNFa plasma concentrations. Intensive Care Med 1997; 23: 878-884
15. Starnes HF, Warren RS, Jeevanandam M, Gabrilove JL, Larchian W, Oettgen HF, Brennan MF. Tumor necrosis factor and the acute metabolic response to tissue injury in man. J Clin Invest 1988; 82: 1321-1325
16. Braun N, Giolai M, Rosenfeld S, Banzhaff W, Fretschner R, Weinstock C, Erley C, Muller GA, Warth H, Northoff H, Risler T. Clearance of Interleukin-6 during continuous venovenous hemofiltration in patients with septic shock - A prospective, controlled clinical study. J Am Soc Nephrol 1993; 4: 336 (Abstract)
17. Lee PA, Matson JR, Pryor RW, Hinshaw LB. Continuous arteriovenous hemofiltration therapy for Staphylococcus aureus-induced septicemia in immature swine. Crit Care Med 1993; 21: 914-924
18. Stein B, Pfenninger E, Grunert A, Schmitz JE, Hudde M. Influence of continuous haemofiltration on haemodynamics and central blood volume in experimental endotoxic shock. Intensive Care Med 1990; 16: 494-499
19. Stein B, Pfenninger E, Grunert A, Schmitz JE, Deller A, Kocher F. The consequences of continuous haemofiltration on lung mechanics and extravascular lung water in a porcine endotoxic shock model. Intensive Care Med 1991; 17: 293-298
20. Grootendorst AF, van Bommel EF, van der Hoven B, van Leengoed LA, van Osta GA. High volume hemofiltration improves hemodynamics in endotoxin-induced shock in the pig. J Crit Care 1992; 7: 67-75
21. Grootendorst AF, van Bommel EF, van Leengoed LA, Nabuurs M, Bouman CS, Groeneveld AB. High volume hemofiltration improves hemodynamics and survival of pigs exposed to gut ischemia and reperfusion. Shock 1994; 2: 72-78
22. Gomez A, Wang R, Unruh H, Light RB, Bose D, Chau T, Correa E, Mink S. Hemofiltration reverses left ventricular dysfunction during sepsis in dogs. Anesthesiology 1990; 73: 671-685
23. Freeman BD, Yatsiv I, Natanson C, Solomon MA, Quezado ZM, Danner RL, Banks SM, Hoffman WD. Continuous arteriovenous hemofiltration does not improve survival in a canine model of septic shock. J Am Coll Surg 1995; 180: 286-292
24. Grootendorst AF, van Bommel EF, van Leengoed LA, van Zanten AR, Huipen HJ, Groeneveld AB. Infusion of ultrafiltrate from endotoxemic pigs depresses myocardial performance in normal pigs. J Crit Care 1993; 8: 161-169
25. Coraim FJ, Coraim HP, Ebermann R, Stellwag FM. Acute respiratory failure after cardiac surgery: clinical experience with the application of continuous arteriovenous hemofiltration. Crit Care Med 1986; 14: 714-718
26. Garzia F, Todor R, Scalea T. Continuous arteriovenous hemofiltration countercurrent dialysis in acute respiratory failure. J Trauma 1991; 31: 1277-1285
27. Cosentino F, Paganini E, Lockrem J, Stoller J, Wiedemann H. Continuous arteriovenous hemofiltration in the adult respiratory distress syndrome. Contrib Nephrol 1991; 93: 94-97
28. Manasia A, Ezeugwu C, Geffroy V, Delgiudice R, Hufanda J, Hannon E, Oropello J, Leibowitz A, Nfonoyim J, Stein J, Glabman S, Benjamin E. The role of continuous veno-venous hemofiltration in the management of acute respiratory distress syndrome - A randomized prospective trial. Blood Purif 1995; 13: 393 (Abstract)
29. Davenport A, Will EJ, Davidson AM. Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure. Crit Care Med 1993; 21: 328-338
30. Matamis D, Tsagourias M, Koletsos K, Riggos D, Mavromatidis K, Sombolos K, Bursztein S. Influence of continuous haemofiltration-related hypothermia on haemodynamic variables and gas exchange in septic patients. Intensive Care Med 1994; 20: 431-436
31. Jakob SM, Frey FJ, Uehlinger DE. Does continuous renal replacement therapy favourably influence the outcome of the patients? Nephrol Dial Transplant 1996; 11: 1250-1255
32. Simpson K, Allison ME. Dialysis and acute renal failure: can mortality be improved? Nephrol Dial Transplant 1993; 8: 946 (abstract)
33. Metha R, McDonald B, Gabbai F, Pahl M, Farkas A, Pascual M, Fowler W and ARF collaborative study group. Continuous versus intermittent dialysis for acute renal failure (ARF) in the ICU: results from a randomized multicenter trial. J Am Soc Nephrol 1996; 7: 1457 (abstract)
34. Kierdorf H, Sieberth HG. Continuous treatment modalities in acute renal failure. Nephrol Dial Transplant 1995; 10: 2001-2008